vimarsana.com
Home
Live Updates
Portage Biotech : NOTICE TO READER OF CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS - Form 6-K -Today at 05:30 pm : vimarsana.com
Portage Biotech : NOTICE TO READER OF CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS - Form 6-K -Today at 05:30 pm
NOTICE TO READER OF CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
The condensed consolidated interim financial statements of Portage Biotech Inc. are comprised of the...
Related Keywords
Delaware
,
United States
,
France
,
Canada
,
British Virgin Islands
,
Lincoln Park
,
Paris
,
France General
,
Road Town
,
British Virgin Islands General
,
United Kingdom
,
Luxembourg
,
Westport
,
Newfoundland
,
Canadian
,
British
,
Mark Simon
,
Stimunity Sa
,
Ian Walters
,
James Mellon
,
Linda Kozick
,
Oncomer Saugatuck
,
Allan Shaw
,
Cantor Fitzgerald Co
,
Details Of The Company
,
Party Transactions
,
Portage Merger Subi Inc
,
Saugatuck Therapeutics Ltd
,
Nasdaq
,
Master Services Agreement
,
Share Exchange Agreement
,
Intensity Holdings Limited
,
Ox Share Exchange On
,
Labcorp Drug Development Inc
,
Intensity Therapeutics Inc
,
Impetis Biosciences
,
Nekonal Oncology Limited
,
Services Agreements
,
Portage Development Services Inc
,
International Financial Reporting Interpretations Committee
,
Salvarx Group
,
Fortrea Inc
,
International Accounting Standards Board
,
Ox Share Exchange Agreement
,
Contract Research Organization
,
Discussion Group Public Meeting
,
Portage Biotech Inc
,
Canadian Securities Exchange
,
Owners Of The Company
,
Audit Committee
,
Company On
,
While The Company
,
Investment In Public Company
,
Salvarx Limited
,
Company Or Portage
,
Compensation Committee
,
Service Agreement
,
Tarus Therapeutics
,
Exchange Commission
,
Parexel International
,
Lincoln Park Capital Fund
,
Service Agreements
,
Portage Merger Sub
,
Company The Salvarx Acquisition
,
Company Nasdaq
,
Investments In Associates
,
Services Agreement
,
Share Exchange Agreement The
,
Saugatuck Rx
,
Hox Therapeutics Ltd
,
Fast Forward Innovations Limited
,
International Financial Reporting Standards
,
Tarus Therapeutics Inc
,
Cantor Fitzgerald
,
Rift Biotherapeutics Inc
,
Portage Biotech
,
International Financial Reporting
,
Chief Executive Officer
,
Consolidated Interim Statements
,
Contingent Liabilities
,
Months Ended June
,
Three Months Ended June
,
Committed Purchase Agreement
,
Condensed Consolidated Interim Financial
,
Clarence Thomas Building
,
Portage Development Services
,
Nasdaq Capital Market
,
Salvarx Acquisition
,
Intensity Therapeutics
,
Saugatuck Therapeutics
,
Exchange Agreement
,
Financial Reporting
,
International Financial Reporting Interpretations
,
British Virgin
,
Stimunity Convertible Note
,
Significant New
,
Time Adoption
,
Accounting Standards
,
Its Associate
,
Financial Statements
,
Joint Ventures
,
Rights Held
,
Shareholder Agreement
,
Maturity Date
,
Common Shares
,
Minimum Raise
,
Convertible Note
,
Merger Agreement
,
License Agreement
,
Impetis Biosciences Limited
,
Call Option
,
Tarus License Agreement
,
Adenosine Compounds
,
Tarus Therapeutic
,
Multi Period Excess Earnings Method
,
Replacement Cost Method
,
Registration Statement
,
Controlled Equity Offering Sales Agreement
,
Sales Agreement
,
Securities Act
,
Purchase Agreement
,
Purchase Shares
,
Committed Purchase
,
Depository Trust Company
,
Nasdaq See Note
,
Option Plan
,
Incentive Plan
,
Stock Options
,
Restricted Stock
,
Subsidiary Plan
,
Work Order
,
Stimunity Convertible
,
Signing Date
,
Registration Rights Agreement
,
Tarus Merger Agreement
,
Group Public Meeting
,
Financial Liabilities
,
Equity Instruments
,
Per Share Earnout Price
,
Earnout Shares
,
Good Reason
,
Just Cause
,
Severance Benefits
,
Termination Date
,
Accrued Obligations
,
Control Severance Benefits
,
Executive Services Agreements
,
Executive Services Agreement
,
Base Salary
,
Nominating Committee
,
Note Receivable
,
Public Company
,
Upon Intensity
,
Equity Issuable
,
Purchase Price Payable
,
Income Approach
,
Liquidity Risk
,
Foreign Currency
,
Markets
,
vimarsana.com © 2020. All Rights Reserved.